Lost password ?
SIPHAT
A Q3 better than expected
- "SIPHAT has beaten our estimates in Q3 2022 and increased its revenues by 106%. Sales to pharmacies decreased by 59%, and sales to hospitals jumped by 244%. "
Executive summary
Conflicts of Interest
Pages 36
Language English
Publish on October 30, 2022
€ 500
VAT Exl.
You may also be interested by these reports :
FIND A REPORT
SIMPLE, TO THE POINT IDEA GENERATION
Each company is researched in depth using a structured, robust and transparent process. Valuations are disciplined and dispassionate.
AlphaMena allows you to compare stocks along a wide range of parameters be it by sector, by geography or an array of investment themes.
Our reports include actuarial as well as off balance-sheet data and governance metrics.
Priority is given to idea generation through quick, to the point, answers by means of browsing from one idea to the next.